Restenosis: delineating the numerous causes of drug-eluting stent restenosis

Circ Cardiovasc Interv. 2011 Apr 1;4(2):195-205. doi: 10.1161/CIRCINTERVENTIONS.110.959882.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Atherosclerosis / etiology
  • Coronary Restenosis / etiology*
  • Drug Hypersensitivity / etiology
  • Drug-Eluting Stents / adverse effects*
  • Humans
  • Matrix Metalloproteinase 2 / blood
  • Matrix Metalloproteinase 9 / blood
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects
  • Shear Strength
  • Sirolimus / administration & dosage
  • Sirolimus / adverse effects

Substances

  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
  • Paclitaxel
  • Sirolimus